South Korea Mammography Market Size (2024 - 2029)

The mammography market in South Korea is poised for significant expansion over the forecast period, driven by factors such as the increasing incidence of breast cancer and advancements in breast imaging technology. Despite the challenges posed by the COVID-19 pandemic, the country's robust healthcare system and strategic planning ensured the continuity of cancer care, including mammography screenings. The integration of artificial intelligence in diagnostic processes and the high adoption rate of advanced mammography technologies, like tomosynthesis, are further contributing to the market's growth. These elements collectively enhance the market's capacity and accessibility, supporting its upward trajectory.

Market Size of South Korea Mammography Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 72.80 Million
Market Size (2029) USD 114.04 Million
CAGR (2024 - 2029) 9.39 %
Market Concentration Medium

Major Players

South Korea Mammography Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

South Korea Mammography Market Analysis

The South Korea Mammography Market size is estimated at USD 72.80 million in 2024, and is expected to reach USD 114.04 million by 2029, growing at a CAGR of 9.39% during the forecast period (2024-2029).

The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. Ensuring continuity of cancer care while fighting COVID-19 has been hugely challenging for South Korea. Even though the country was known to have the highest number of COVID-19 infections in the initial phase of the pandemic, it was able to efficaciously flatten the curve of these infections in a shorter period of time without extreme measures.

Countering rapidly to the circumstances and working in accordance with the South Korean government's COVID-19 policies, several private hospitals contained and handled COVID-19, infected patients, from areas wherein the healthcare amenities were overwhelmed. In the time being, public hospitals succeeded in keeping up with daily routines, and a maximum of the cancer centers across South Korea was able to support cancer care continuity under the systematic planning and planned resource allocation complying with the Korean Centers of Disease Control and Prevention (KCDC). This greatly boosted the uptake of mammograms among women as all the screening facilities were operational. Therefore, COVID-19 did not have a huge impact on the cancer screenings in South Korea.

South Korea has one of the highest per-capita income levels in not only the Asia-Pacific region but also the world. The country has seen its economy grow tremendously over the last few years. It thus has a well-funded healthcare system that allows patients to avail of the latest technologies in breast screening like mammography. Factors such as the growing incidences of breast cancer, technological advancements in the field of breast imaging, and the investment from various organizations in breast cancer screening campaigns.

Furthermore, as per the data from National Institute of Health 2021, mammography companies in South Korea are making use of artificial intelligence to deliver the best possible care to their patients. South Korean hospitals and clinics are using AI technology for various purposes, such as detecting breast cancer and reducing medical errors. The AI-powered systems also helped reduce the time spent on administrative tasks. As a result, doctors were able to spend more time on patient care, which will lead to better outcomes. Such factors are bolstering the market growth within the country. In addition, the adoption of tomosynthesis (3D mammography) is very high in South Korea, and it is replacing conventional mammography devices at a rapid rate. 

Hence, with the above-mentioned factors, the market studied is expected to witness strong growth over the forecast period.

South Korea Mammography Industry Segmentation

As per the scope of the report, mammography refers to a standard diagnostic and screening technique that is used to screen breast tissues to check the presence of a malignant tumor. The process involves the usage of low-energy X-rays for the early detection of breast cancer. South Korea Mammography Market is segmented by Product Type (Digital Systems, Analog Systems, Breast Tomosynthesis, and Other Product Types), End Users (Hospitals, Specialty Clinics, and Diagnostic Centers). The report offers the value (in USD million) for the above segments.

By Product Type
Digital Systems
Analog Systems
Breast Tomosynthesis
Other Product Types
By End User
Hospitals
Specialty Clinics
Diagnostic Centers
Need A Different Region Or Segment?
Customize Now

South Korea Mammography Market Size Summary

The South Korean mammography market is poised for significant growth, driven by a combination of factors including technological advancements and a robust healthcare infrastructure. Despite the challenges posed by the COVID-19 pandemic, which initially disrupted cancer care, South Korea managed to maintain continuity in cancer screenings, including mammograms, thanks to effective government policies and resource allocation. The country's high per-capita income and well-funded healthcare system enable the adoption of cutting-edge breast screening technologies, such as mammography and digital breast tomosynthesis. The increasing incidence of breast cancer and the integration of artificial intelligence in diagnostic processes further bolster market expansion, as these technologies enhance diagnostic accuracy and efficiency.

The market is characterized by the presence of major players like Canon Medical Systems Corporation, Fujifilm Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, and Siemens Healthineers, who are focusing on technological innovations and minimizing procedural side effects. The adoption of advanced technologies, such as 3D mammography and DBT, is rapidly replacing conventional methods, improving diagnostic capabilities. Research and development in fusion imaging techniques and AI-powered systems are contributing to better patient outcomes and driving market growth. The South Korean mammography market is expected to continue its upward trajectory, supported by ongoing investments and advancements in breast cancer screening technologies.

Explore More

South Korea Mammography Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Burden of Breast Cancer

      2. 1.2.2 Technological Advancements in the Field of Breast Imaging

    3. 1.3 Market Restraints

      1. 1.3.1 Risk of Adverse Effects from Radiation Exposure

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product Type

      1. 2.1.1 Digital Systems

      2. 2.1.2 Analog Systems

      3. 2.1.3 Breast Tomosynthesis

      4. 2.1.4 Other Product Types

    2. 2.2 By End User

      1. 2.2.1 Hospitals

      2. 2.2.2 Specialty Clinics

      3. 2.2.3 Diagnostic Centers

South Korea Mammography Market Size FAQs

The South Korea Mammography Market size is expected to reach USD 72.80 million in 2024 and grow at a CAGR of 9.39% to reach USD 114.04 million by 2029.

In 2024, the South Korea Mammography Market size is expected to reach USD 72.80 million.

Mammography Market in South Korea Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)